What question did this study set out to answer?

The aim is to evaluate the effectiveness and safety of sarilumab in treating polymyalgia rheumatica.

March 18, 2026Modern Rheumatology0 citations

Effectiveness and Safety of Sarilumab in Polymyalgia Rheumatica: a retrospective study of the FIRST Registry

The aim is to evaluate the effectiveness and safety of sarilumab in treating polymyalgia rheumatica.
Retrospective analysis of data from the FIRST Registry
Comparison of sarilumab with conventional therapy
Assessment of disease activity measures
Sarilumab shows improvement in disease activity compared to conventional therapy
Data indicate potential benefits in safety profile

These findings suggest that sarilumab may have the potential to improve disease activity in polymyalgia rheumatica compared to conventional therapy.

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper

Ohkubo et al. (Fri,) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper